February 23, 2015 9:44 AM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares jumped 43.53% to $3.66 after the company reported a research collaboration with
Bristol-Myers Squibb (NYSE: BMY).
Digital Ally Inc. (NASDAQ: DGLY) shares gained 25.75% to $13.88 after the company reported that it has been awarded a 5 year GSA contract.
Biocept, Inc. (NASDAQ: BIOC) shares climbed 22.37% to $1.77 after the company reported favorable findings from OncoCEE-BR Study.
Celldex Therapeutics, Inc. (NASDAQ: CLDX) jumped 19.28% to $25.30 after the company announced a breakthrough designation from the FDA for its Rintega therapy.
Intellicheck Mobilisa, Inc. (NYSE: IDN) rose 14.22% to $1.6790 after the company reported that it has signed a contract with Helzberg Diamonds to implement ID Check at all U.S. retail locations.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) surged 12.73% to $195.31 after the company agreed to acquire
Salix Pharmaceuticals (NASDAQ: SLXP) for $10 billion.
Polypore International Inc. (NYSE: PPO) gained 12.26% to $59.44. Asahi Kasei Corporation agreed to acquire Polypore for $60.50 per share in cash. Polypore also announced the sale of its media business to
3M Company (NYSE: MMM) for $1 billion.
Tower Semiconductor Ltd. (NASDAQ: TSEM) shares surged 10.08% to $15.07 after the company reported stronger-than-expected earnings for the fourth quarter.
Ballard Power Systems Inc.(NASDAQ: BLDP) shares climbed 9.96% to $2.65 after the company reported the signing of two new technology solutions contracts.
Home Loan Servicing Solutions, Ltd. (NASDAQ: HLSS) shares jumped 8.77% to $18.23 after
New Residential Investment Corp. (NYSE: NRZ) announced its plans to acquire HLSS for $18.25 per share in cash
ADMA Biologics, Inc. (NASDAQ: ADMA) shares rose 4.96% to $11.00 after announced positive data from phase III RI-002 trial.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.